Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP458436.RAFJ3OchsupoVxfhwgQm2kX0GO506uu6VpJOljsUNs2NA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP458436.RAFJ3OchsupoVxfhwgQm2kX0GO506uu6VpJOljsUNs2NA130_assertion type Assertion NP458436.RAFJ3OchsupoVxfhwgQm2kX0GO506uu6VpJOljsUNs2NA130_head.
- NP458436.RAFJ3OchsupoVxfhwgQm2kX0GO506uu6VpJOljsUNs2NA130_assertion description "[Various doses of I-131 (75, 300, 600, 1,200, and 2,400 microCi/5 mL) were incubated with hNIS-expressing colon cancer (CT26/hNIS) and parental cells (CT26), and numbers of MHC class I and Fas-expressing cells were determined by fluorescence-activated cell sorting (FACS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP458436.RAFJ3OchsupoVxfhwgQm2kX0GO506uu6VpJOljsUNs2NA130_provenance.
- NP458436.RAFJ3OchsupoVxfhwgQm2kX0GO506uu6VpJOljsUNs2NA130_assertion evidence source_evidence_literature NP458436.RAFJ3OchsupoVxfhwgQm2kX0GO506uu6VpJOljsUNs2NA130_provenance.
- NP458436.RAFJ3OchsupoVxfhwgQm2kX0GO506uu6VpJOljsUNs2NA130_assertion SIO_000772 20053774 NP458436.RAFJ3OchsupoVxfhwgQm2kX0GO506uu6VpJOljsUNs2NA130_provenance.
- NP458436.RAFJ3OchsupoVxfhwgQm2kX0GO506uu6VpJOljsUNs2NA130_assertion wasDerivedFrom befree-20150227 NP458436.RAFJ3OchsupoVxfhwgQm2kX0GO506uu6VpJOljsUNs2NA130_provenance.
- NP458436.RAFJ3OchsupoVxfhwgQm2kX0GO506uu6VpJOljsUNs2NA130_assertion wasGeneratedBy ECO_0000203 NP458436.RAFJ3OchsupoVxfhwgQm2kX0GO506uu6VpJOljsUNs2NA130_provenance.